Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug aims to unleash immune system on Hard-to-Treat cancers

NCT ID NCT07205718

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 27 times

Summary

This study tests a new medicine, TAK-188, designed to help the immune system fight advanced solid tumors that haven't responded to standard treatments. TAK-188 targets and removes certain cells inside tumors that weaken the immune response, potentially allowing cancer-fighting cells to attack the tumor. About 223 adults will receive TAK-188 for up to one year, with monitoring for safety and tumor response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC SOLID TUMORS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Barbara Ann Karmanos Cancer Institute

    RECRUITING

    Detroit, Michigan, 48201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Florida Cancer Specialists - Lake Nona

    RECRUITING

    Orlando, Florida, 32827, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Fox Chase Cancer Center

    RECRUITING

    Philadelphia, Pennsylvania, 19111-2497, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Johns Hopkins

    NOT_YET_RECRUITING

    Baltimore, Maryland, 21231, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • MD Anderson Cancer Center

    NOT_YET_RECRUITING

    Houston, Texas, 77030-4000, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • NEXT Dallas

    RECRUITING

    Irving, Texas, 75039, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • NEXT Virginia

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Providence Cancer Institute, Franz Clinic

    NOT_YET_RECRUITING

    Portland, Oregon, 97213-2933, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • SCRI Oncology

    RECRUITING

    Nashville, Tennessee, 37203, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • START Midwest

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • START San Antonio

    RECRUITING

    San Antonio, Texas, 78229, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • UCLA Health-Santa Monica Cancer Care (Cancer Care - Santa Monica)

    NOT_YET_RECRUITING

    Santa Monica, California, 90404, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospitals Cleveland Medical Center

    RECRUITING

    Cleveland, Ohio, 44106-1716, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Washington University

    RECRUITING

    St Louis, Missouri, 63108, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yale School of Medicine - Smilow Cancer Hospital - Center for Thoracic Cancers

    RECRUITING

    New Haven, Connecticut, 06511, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.